← Back to Blog
Share

Abbott Clears Ultreon™ 3.0 for U.S. and Europe: What AI-Powered Coronary Imaging Means for MedTech Sales

Abbott announced FDA clearance and CE Mark for Ultreon™ 3.0, combining OCT coronary imaging with AI-driven insights for PCI. Here is what the news signals for interventional cardiology sales teams and hiring managers in 2026.

Published May 9, 20266 min read

On April 28, 2026, Abbott announced U.S. Food and Drug Administration (FDA) clearance and CE Mark for Ultreon™ 3.0 Software—positioning the release as a next step that pairs high-resolution optical coherence tomography (OCT) coronary imaging with AI-automated insights in one workflow for percutaneous coronary intervention (PCI).

For medical device sales professionals who call on cath labs and support complex PCI programs, launches like this are less about a single software version and more about where the market is investing: faster image acquisition, clearer planning support, and tighter integration between imaging and the broader coronary portfolio.

What Abbott Announced (In Plain Terms)

  • Ultreon™ 3.0 is described as the first advanced OCT system in the U.S. and Europe that integrates high-resolution coronary plaque imaging with AI-automated insights along the vessel.
  • The platform is intended to support real-time planning during PCI, including assessment of plaque characteristics to help physicians choose stent location and sizing.
  • Abbott highlights a one-second OCT pullback, contrast-sparing options that may matter for some patients with kidney disease, and post-procedure assessment to review stent results.

Why Sales Teams Should Pay Attention

Coronary imaging is already a crowded conversation—OCT, IVUS, physiology, and co-registration each have strong advocates. When a major OEM advances software-led differentiation, field teams typically see a few predictable shifts: refreshed training priorities, updated messaging for physicians and staff, and more cross-functional selling that touches imaging, consumables, and capital.

Reps who can speak credibly about workflow (setup time, pullbacks, integration into the lab’s standard PCI pathway) and can align clinical stories with hospital quality and efficiency goals are usually the ones who keep traction as products get more software-centric.

MedSales Network does not provide clinical advice or product training—always follow your employer’s approved labeling, instructions for use, and compliance policies in customer conversations.

What Employers and Candidates Should Expect

  • Hiring profiles may emphasize digital fluency and the ability to coordinate with applications specialists or imaging experts—not only “bag-carry” fundamentals.
  • Territory planning can tilt toward accounts investing in complex PCI programs, hub-and-spoke referral networks, and structured training for new imaging workflows.
  • Interview preparation should include how you learn new platforms quickly, how you partner with physicians and cath lab staff, and how you document customer interactions responsibly.
Explore Medical Sales Jobs